E

Hot Topics: What we learned from SITC20 about an emerging class of oncology agents

A look at several different innate immune system approaches

November 18, 2020
E

ASH20 Preview of progress with bispecific antibodies

Updated look at the bispecific landscape in early clinical development

November 9, 2020